眼科診療ビジュアルラーニング　6　黄斑部

出版社： 中山書店
著者：
発行日： 2020-12-21
分野： 臨床医学：外科  >  眼科学
ISBN： 9784521745152
電子書籍版： 2020-12-21 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

12,100 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

12,100 円(税込)

購入する

商品紹介

ここ数年，OCT,OCT Angiographyなど検査機器の進歩によって，眼底部とくに網膜外層，脈絡膜とその毛細血管層を微細に観察できるようになり，病態の理解が進んだ．
パキコロイド関連疾患など，新しい疾患の枠組みが提唱されている．
本巻では，画像を満載し，これらの新知見を含めた黄斑疾患の基礎から診療の実際までをまとめる．

目次

  • 1．基礎編
    　構造と機能
    　検査法
    　治療法の概要

    2．診断編
    　網膜硝子体界面病変
    　加齢黄斑変性
    　pachychoroid 関連疾患
    　黄斑部毛細血管拡張症
    　特発性脈絡膜新生血管
    　網膜色素線条
    　病的近視
    　黄斑ジストロフィ
    　続発性脈絡膜新生血管

    3．診療編
    　網膜硝子体界面病変／黄斑上膜
    　網膜硝子体界面病変／黄斑偽円孔、分層円孔
    　網膜硝子体界面病変／黄斑円孔
    　網膜硝子体界面病変／乳頭ピット黄斑症
    　網膜硝子体界面病変／硝子体黄斑牽引症候群
    　加齢黄斑変性／ドルーゼン
    　加齢黄斑変性／網膜色素上皮剥離
    　加齢黄斑変性／典型滲出型加齢黄斑変性
    　加齢黄斑変性／ポリープ状脈絡膜血管症
    　加齢黄斑変性／網膜血管腫状増殖
    　加齢黄斑変性／pachychoroid neovasculopathy
    　加齢黄斑変性／萎縮型加齢黄斑変性
    　中心性漿液栄脈絡網膜症関連／中心性漿液性脈絡網膜症
    　中心性漿液栄脈絡網膜症関連／pachychoroid pigment epitheliopathy
    　中心性漿液栄脈絡網膜症関連／focal choroidal excavation (FCE)
    　黄斑部毛細血管拡張症／黄斑部毛細血管拡張症 Type 1
    　黄斑部毛細血管拡張症／黄斑部毛細血管拡張症 Type 2
    　新生血管黄斑症／特発性黄斑下脈絡膜新生血管
    　新生血管黄斑症／網膜色素線条
    　近視関連／病的近視
    　近視関連／近視性脈絡膜新生血管
    　近視関連／近視性中心窩分離症と黄斑円孔網膜剥離
    　近視関連／dome-shaped macula
    　近視関連／tilted disc syndrome
    　黄斑ジストロフィ／卵黄状黄斑ジストロフィ
    　黄斑ジストロフィ／Stargards病
    　黄斑ジストロフィ／三宅病（RP1L1 関連黄斑ジストロフィ）
    　黄斑ジストロフィ／中心性輪紋状脈絡膜ジストロフィ
    　特発性黄斑分離
    　macular microhole
    paracentral acute middle maculopathy (PAMM)
    unilateral acute idiopathic maculopathy (UAIM)
    　ヒドロキシクロロキン網膜症
    　パクリタキセル網膜症
    　タモキシフェン網膜症

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 基礎編

P.5 掲載の参考文献
1) Spaide RF, et al : Anatomical correlates to the bands seen in the outer retina by optical coherence tomography : literature review and model. Retina 2011 ; 31 : 1609-1619.
 
2) Staurenghi G, et al : Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography : the IN・OCT consensus. International Nomenclature for Optical Coherence Tomography (IN・OCT) Panel. Ophthalmology 2014 ; 121 : 1572-1578.
 
P.14 掲載の参考文献
1) Song WK, et al : Macular thickness variations with sex, age, and axial length in healthy subjects : a spectral domain-optical coherence tomography study. Invest Ophthalmol Vis Sci 2010 ; 51 : 3913-3918.
PubMed
P.15 掲載の参考文献
1) Leung CK,et al : Comparison of macular and peripapillary measurements for the detection of glaucoma : an optical coherence tomography study. Ophthalmology 2005 ; 112 : 391-400.
PubMed
P.19 掲載の参考文献
1) Otani T, et al : Improved visualization of Henle fiber layer by changing the measurement beam angle on optical coherence tomography. Retina 2011 ; 31 : 497-501.
PubMed
P.48 掲載の参考文献
1) Gass JDM : Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994 ; 118 : 285-298.
 
P.65 掲載の参考文献
1) Tano Y on behalf of the Ophthalmic PDT Study Group : Guidelines for PDT in Japan. Ophthalmology 2008 ; 115 : 585-585. e6.
 
P.68 掲載の参考文献
1) Tano Y ; Ophthalmic PDT Study Group : Guidelines for PDT in Japan. Ophthalmology 2008 ; 115 : 585.
 
P.74 掲載の参考文献
1) 小椋祐一郎ら, 日本網膜硝子体学会硝子体注射ガイドライン作成委員会 : 黄斑疾患に対する硝子体内注射ガイドライン. 日本眼科学会雑誌 2016 ; 120 : 87-90.
 

2 診断編

P.86 掲載の参考文献
1) Yuzawa M, et al : Observation of idiopathic full-thickness macular holes. Follow-up observation. Arch Ophthalmol 1994 ; 112 : 1051-1056.
PubMed
2) Takahashi H, et al : Optical coherence tomography images of spontaneous macular hole closure. Am J Ophthalmol 1999 ; 128 : 519-520.
PubMed
3) Inoue M, et al : Long-term outcome of macular microstructure assessed by optical coherence tomography in eyes with spontaneous resolution of macular hole. Am J Ophthalmol 2012 ; 153 : 687-691.
PubMed
P.105 掲載の参考文献
1) Sato T, et al : Correlation of optical coherence tomography with angiography in retinal pigment epithelial detachment associated with age-related macular degeneration. Retina 2004 ; 24 : 910-914.
PubMed
P.109 掲載の参考文献
1) Sato T, et al : Correlation of optical coherence tomography with angiography in retinal pigment epithelial detachment associated with age-related macular degeneration. Retina 2004 ; 24 : 910-914.
PubMed
P.139 掲載の参考文献
1) Warrow DJ, et al : Pachychoroid pigment epitheliopathy. Retina 2013 ; 33 : 1659-1672. doi : 10.1097/IAE.0b013e3182953df4
 
2) Spaide RF : DISEASE EXPRESSION IN NONEXUDATIVE AGE-RELATED MACULAR DEGENERATION VARIES WITH CHOROIDAL THICKNESS. Retina 2018 ; 38 : 708-716. doi : 10.1097/IAE.0000000000001689
 
3) Takahashi A, et al : Pachychoroid Geographic Atrophy : Clinical and Genetic Characteristics. Ophthalmol Retina 2018 ; 2 : 295-305. doi : 10.1016/j.oret.2017.08.016
 
4) Pang CE, et al : Pachychoroid neovasculopathy. Retina 2015 ; 35 : 1-9. doi : 10.1097/IAE.0000000000000331
 
5) Miyake M, et al : Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 2015 ; 5 : 16204. doi : 10.1038/srep16204
 
P.157 掲載の参考文献
1) Morgan IG, et al : Myopia. Lancet 2012 ; 379 : 1739-1748.
PubMed
2) Ohno-Matsui K, et al : Long-term development of significant visual field defects in highly myopic eyes. Am J Ophthalmol 2011 ; 152 : 256-265.
PubMed
P.171 掲載の参考文献
1) Miyake Y, et al : Hereditary macular dystrophy without visible fundus abnormality. Am J Ophthalmol 1989 ; 108 : 292-299.
PubMed
2) Miyake Y, et al : Occult macular dystrophy. Am J Ophthalmol 1996 ; 122 : 644-653.
PubMed
3) Akahori M, et al : Dominant mutations in RP1L1 are responsible for occult macular dystrophy. Am J Hum Genet 2010 ; 87 : 424-429.
PubMed

3 診療編

P.181 掲載の参考文献
1) Tsuchiya S, et al : Visual field changes after vitrectomy with internal limiting membrane peeling for epiretinal membrane or macular hole in glaucomatous eyes. PLoS One 2017 ; 12 : e0177526.
 
2) Yoshida M, et al : Efficacy of 27-Gauge Vitrectomy with Internal Limiting Membrane Peeling for Epiretinal Membrane in Glaucoma Patients. J Ophthalmol 2019 ; 2019 : 7807432.
PubMed
3) Tsuchiya S, et al : Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane : topographic characteristics and risk factors. Eye (Lond). 2020 May 28. doi : 10.1038/s41433-020-0996-8. Online ahead of print.
 
P.185 掲載の参考文献
1) Govetto A, et al : Lamellar Macular Hole : Two Distinct Clinical Entities? Am J Ophthalmol 2016 ; 164 : 99-109.
PubMed
2) Hirano M, et al : Assessment of Lamellar Macular Hole and Macular Pseudohole With a Combination of En Face and Radial B-scan Optical Coherence Tomography Imaging. Am J Ophthalmol 2018 ; 188 : 29-40.
PubMed
3) Figueroa MS, et al : PARS PLANA VITRECTOMY FOR THE TREATMENT OF TRACTIONAL AND DEGENERATIVE LAMELLAR MACULAR HOLES : Functional and Anatomical Results. Retina 2019 ; 39 : 2090-2098.
PubMed
4) Purtskhvanidze K, et al : Long-term follow-up of lamellar macular holes and pseudoholes over at least 5 years. Graefes Arch Clin Exp Ophthalmol 2018 ; 256 : 1067-1078.
PubMed
5) Parolini B, et al : Lamellar macular hole : a clinicopathologic correlation of surgically excised epiretinal membranes. Invest Ophthalmol Vis Sci 2011 ; 52 : 9074-9083.
PubMed
6) Shiraga F, et al : Modified vitreous surgery for symptomatic lamellar macular hole with epiretinal membrane containing macular pigment. Retina 2013 ; 33 : 1263-1269.
PubMed
7) Shiode Y, et al : Embedding of lamellar hole-associated epiretinal proliferation combined with internal limiting membrane inversion for the treatment of lamellar macular hole : a case report. BMC Ophthalmol 2018 ; 18 : 257.
PubMed
8) Takahashi K, et al : Results of lamellar macular hole-associated epiretinal proliferation embedding technique for the treatment of degenerative lamellar macular hole. Graefes Arch Clin Exp Ophthalmol 2019 ; 257 : 2147-2154.
PubMed
P.189 掲載の参考文献
1) Kishi S, et al : The Role of the Premacular Liquefied Pocket and Premacular Vitreous Cortex in Idiopathic Macular Hole Development. Am J Ophthalmol 1996 ; 122 : 622-628.
PubMed
2) Gass JD : Idiopathic Senile Macular Hole. Its Early Stages and Pathogenesis. Arch Ophthalmol 1988 ; 106 : 629-639.
PubMed
P.194 掲載の参考文献
1) Hirakata A, et al : Long-term results of vitrectomy without laser treatment for macular detachment associated with an optic disc pit. Ophthalmology 2005 ; 112 : 1430-1435.
PubMed
2) Hiraoka T, et al : Infrared and fundus autofluorescence imaging in eyes with optic disc pit maculopathy. Clin Exp Ophthalmol 2010 ; 38 : 669-677.
PubMed
3) Rii T, et al : Comparative findings in childhood-onset versus adult-onset optic disc pit maculopathy. Acta Ophthalmol 2013 ; 91 : 429-433.
PubMed
4) 平形明人 : 乳頭ピット黄斑症候群の診断と治療. 坂本泰二 (責任編集) 臨床眼科増刊号. 7年前の常識は現在の非常識. 東京 : 医学書院 ; 2018. p.250-255.
 
P.198 掲載の参考文献
1) Choi JH, et al : Development of idiopathic macular hole in fellow eyes. Retina 2020 ; 40 : 765-772.
PubMed
2) Stalmans P : A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit). Graefes Arch Clin Exp Ophthalmol 2016 ; 254 : 617-628.
PubMed
3) Theodossiadis GP, et al : Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography. Am J Ophthalmol 2014 ; 157 : 842-851.
PubMed
4) Shimada N, et al : Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. Am J Ophthalmol 2012 ; 154 : 693-701.
PubMed
P.204 掲載の参考文献
1) 高橋寛二ら : 加齢黄斑変性の分類と診断基準. 日本眼科学会雑誌 2008 ; 112 : 1076-1084.
Medical*Online
2) 高橋寛二ら : 加齢黄斑変性の治療指針. 日本眼科学会雑誌 2012 ; 116 : 1150-1155.
 
3) Age-Related Eye Disease Study Research Group : A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss : AREDS report no. 8. Arch Ophthalmol 2001 ; 119 : 1417-1436.
 
4) Age-Related Eye Disease Study 2 Research Group : Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration : the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013 ; 309 : 2005-2015.
 
P.209 掲載の参考文献
1) 高橋寛二ら : 厚生労働省網脈絡膜・視神経萎縮症調査研究班加齢黄斑変性診断基準作成ワーキンググループ : 加齢黄斑変性の分類と診断基準. 日本眼科学会雑誌 2008 ; 112 : 1076-1084.
 
2) Saito M, et al : Retinal Pigment Epithelium Tear after Intravitreal Aflibercept Injection. Clin Ophthalmol 2013 ; 7 : 1287-1289.
PubMed
3) Freund KB, et al : Acquired vitelliform lesions : correlation of clinical findings and multiple imaging analyses. Retina 2011 ; 31 : 13-25.
PubMed
4) Saito M, et al : Clinical Findings of Acquired Vitelliform Lesions Associated with Retinal Pigment Epithelial Detachments. Am J Ophthalmol 2014 ; 157 : 355-365.
PubMed
P.212 掲載の参考文献
1) 高橋寛二ら : 加齢黄斑変性の治療指針. 日本眼科学会雑誌 2012 ; 116 : 1150-1155.
 
P.219 掲載の参考文献
1) 高橋寛二ら : 加齢黄斑変性の治療指針. 日本眼科学会雑誌 2012 ; 116 : 1150-1155.
 
2) Wong TY, et al : Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy : two-year results of the aflibercept in polypoidal choroidal vasculopathy study. Am J Ophthalmol 2019 ; 204 : 80-89.
PubMed
3) Koh A, et al : EVEREST II study group. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy : a randomized clinical trial. JAMA Ophthalmol 2017 ; 135 : 1206-1213.
PubMed
4) Ohji M, et al : Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998 ; 116 : 1326-1332.
PubMed
5) Kitagawa Y, et al : Intravitreal tissue plasminogen activator, Ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy. Ophthalmology 2016 ; 123 : 1278-1286.
PubMed
6) Kimura S, et al : Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator. Am J Ophthalmol 2015 ; 159 : 683-689.
PubMed
P.223 掲載の参考文献
1) 吉村長久 : 網膜血管腫状増殖. 吉村長久編. 加齢黄斑変性 第2版. 東京 : 医学書院 ; 2016. p.123-128.
 
P.228 掲載の参考文献
1) Roy R, et al : Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor. Indian J Ophthalmol 2019 ; 67 : 1678-1683.
PubMed
2) Koh A, et al : Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy : A Randomized Clinical Trial. JAMA Ophthalmol 2017 ; 135 : 1206-1213.
 
3) Pang CE, et al : Pachychoroid neovasculopathy. Retina 2015 ; 35 : 1-9.
PubMed
4) Lee J, et al : Drusen Subtypes and Choroidal Characteristics in Asian Eyes with Typical Neovascular Age-Related Macular Degeneration. Retina 2020 ; 40 : 490-498.
PubMed
5) 高橋寛二ら : 加齢黄斑変性の治療指針. 日本眼科学会雑誌 2012 ; 116 : 1150-1155.
 
P.235 掲載の参考文献
1) 高橋寛二ら : 萎縮型加齢黄斑変性の診断基準. 日本眼科学会雑誌 2015 ; 119 : 671-677.
 
2) 高橋寛二 : 加齢黄斑変性における黄斑萎縮. 眼科 2019 ; 61 : 1373-1382.
 
3) Sunnes JS, et al : The long-term natural history of geographic atrophy from age-related macular degeneration. Enlargement of atrophy and implications for interventional clinical trials. Ophthalmology 2007 ; 114 : 271-277.
 
4) Finger RP, et al : Reticular pseudodrusen. A risk for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. Ophthalmology 2014 ; 121 : 1252-1256.
PubMed
P.240 掲載の参考文献
1) Daruich A, et al : Central serous chorioretinopathy : Recent findings and new physiopathology hypothesis. Prog Retin Eye Res 2015 ; 48 : 82-118.
PubMed
2) Izumi T, et al : Differences in choroidal structures between idiopathic and steroid-induced central serous chorioretinopathy. J Vitreoretin Dis 2018 ; 3 : 10-15.
 
3) Yannuzzi LA, et al : Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy : A Pilot Study. Retina 2003 ; 23 : 288-298.
PubMed
4) Fujita K, et al : One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 2015 ; 122 : 555-561.
PubMed
5) Reibaldi M, et al : Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy : A Nonrandomized Clinical Trial. Am J Ophthalmol 2009 ; 149 : 307-315.
PubMed
6) Maruko I, et al : Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy. PLoS One 2017 ; 12 : e0184112.
PubMed
7) Roca JA, et al : Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy : Results of the Pan-American Collaborative Retina Study (PACORES) Group. Br J Ophthalmol 2018 ; 102 : 1696-1700.
PubMed
8) Van Dijk EHC, et al : Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy : The PLACE Trial. Ophthalmology 2018 ; 125 : 1547-1555.
PubMed
P.251 掲載の参考文献
1) Jampol LM, et al : Diagnostic and therapeutic challenges. Retina 2006 ; 26 : 1072-1076.
PubMed
2) Margolis R, et al : The expanded spectrum of focal choroidal excavation. Arch Ophthalmol 2011 ; 129 : 1320-1325.
PubMed
3) Ellabban AA, et al : Focal choroidal excavation in eyes with central serous chorioretinopathy. Am J Ophthalmol 2013 ; 156 : 673-683.
PubMed
4) Kuroda Y, et al : Association of focal choroidal excavation with age-related macular degeneration. Invest Ophthalmol Vis Sci 2014 ; 55 : 6046-6054.
PubMed
5) Chung H, et al : Focal choroidal excavation and its association with pachychoroid spectrum disorders : A review of the literature and multimodal imaging findings. Retina 2017 ; 37 : 199-221.
PubMed
P.256 掲載の参考文献
1) Yannuzzi LA, et al : Idiopathic macular telangiectasia. Arch Ophthalmol 2006 ; 124 : 450-460.
PubMed
2) Maruko I, et al : Demographic features of idiopathic macular telangiectasia in Japanese patients. Jpn J Ophthalmol 2012 : 56 ; 152-158.
PubMed
3) Hirano Y, et al : Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia. Br J Ophthalmol 2010 ; 94 : 600-605.
PubMed
4) Kowalczuk L, et al : EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE. Retina 2017 ; 37 : 2226-2237.
 
5) Feng J, et al : Differences in aqueous concentrations of cytokines in paediatric and adult patients with Coats' disease. Acta Ophthalmol 2017 ; 95 : 608-612.
PubMed
P.260 掲載の参考文献
1) Koizumi H, et al : Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. Am J Ophthalmol 2006 ; 142 : 340-343.
PubMed
2) Koizumi H, et al : Full-thickness macular hole formation in idiopathic parafoveal telangiectasis. Retina 2007 ; 27 : 473-476.
PubMed
P.265 掲載の参考文献
1) Ho AC, et al : The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 1995 ; 102 : 782-789.
PubMed
2) Iida T, et al : Indocyanine green angiographic features of idiopathic submacular choroidal neovascularization. Am J Ophthalmol 1998 ; 126 : 70-76.
PubMed
3) Kumar A, et al : Characterization of Idiopathic Choroidal Neovascularization Using Fluorescein Angiography, Indocyanine Green Angiography, and Optical Coherence Tomography Angiography. Ophthalmic Surg Lasers Imaging Retina 2018 ; 49 : 516-522.
PubMed
4) Macular Photocoagulation Study Group : Argon laser photocoagulation for idiopathic neovascularization. Results of a randomized clinical trial. Arch Ophthalmol 1983 ; 101 : 1358-1361.
 
5) Kang HM, et al : Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Am J Ophthalmol 2013 ; 155 : 713-719.
PubMed
P.270 掲載の参考文献
1) Le Saux O, et al : Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 2000 ; 25 : 223-227.
 
2) Bergen AA, et al : Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000 ; 25 : 228-231.
PubMed
3) Gliem M, et al : Treatment of choroidal neovascularization due to angioid streaks : a comprehensive review. Retina 2013 ; 33 : 1300-1314.
PubMed
4) Spaide RF : Peau d'orange and angioid streaks : manifestations of Bruch membrane pathology. Retina 2015 ; 35 : 392-397.
 
5) Chatziralli I, et al : Angioid streaks : A comprehensive review from pathophysiology to treatment. Retina 2019 ; 39 : 1-11.
PubMed
P.275 掲載の参考文献
1) Ohno-Matsui K, et al : International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 2015 ; 159 : 877-883.
PubMed
2) Hayashi K, et al : Long-term pattern of progression of myopic maculopathy : a natural history study. Ophthalmology 2010 ; 117 : 1595-1611.
PubMed
3) Fang Y, et al : Progression of Myopic Maculopathy during 18-Year Follow-up. Ophthalmology 2018 ; 125 : 863-877.
PubMed
4) Shinohara K, et al : Posterior Staphylomas in Pathologic Myopia Imaged by Widefield Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2017 ; 58 : 3750-3758.
PubMed
5) Jonas JB, et al : Histology of myopic posterior scleral staphylomas. Acta Ophthalmol 2020 ; doi : 10.1111/aos.14405. Online ahead of print.
 
P.279 掲載の参考文献
1) Ohno-Matsui K, et al : International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 2015 ; 159 : 877-883.e7.
 
2) Wolf S, et al : RADIANCE : a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 2014 ; 121 : 682-692.e2.
 
3) Ikuno Y, et al : Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization : The MYRROR Study. Ophthalmology 2015 ; 122 : 1220-1227.
PubMed
4) Ohno-Matsui K, et al : Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res 2018 ; 63 : 92-106.
PubMed
P.284 掲載の参考文献
1) Zhu K, et al : Comparison of the Internal Limiting Membrane Insertion Technique and the Inverted Internal Limiting Membrane Flap Technique with Vitrectomy to Treat Macular Hole-Associated Retinal Detachment. Retina 2020 Apr 14. doi : 10.1097/IAE.0000000000002804.
 
2) Chen SN, et al : Inverted Internal Limiting Membrane Insertion for Macular Hole-Associated Retinal Detachment in High Myopia. Am J Ophthalmol 2016 ; 162 : 99-106. e101.
 
3) Wakabayashi T, et al : Inverted internal limiting membrane insertion versus standard internal limiting membrane peeling for macular hole retinal detachment in high myopia : one-year study. Graefes Arch Clin Exp Ophthalmol 2018 ; 256 : 1387-1393.
PubMed
4) Baba T, et al : Scleral buckling with macular plombe for eyes with myopic macular retinoschisis and retinal detachment without macular hole. Am J Ophthalmol 2006 ; 142 : 483-487.
PubMed
5) Baba T, et al : Scleral Imbrication Combined with Pars Plana Vitrectomy without Internal Limiting Membrane Peeling for Myopic Schisis. Retina 2016 ; 36 : 1927-1934.
PubMed
6) Shimada N, et al : Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. Am J Ophthalmol 2012 ; 154 : 693-701.
PubMed
P.288 掲載の参考文献
1) Gaucher D, et al : Dome-shaped macula in eyes with myopic posterior staphyloma. Am J Ophthalmol 2008 ; 145 : 909-914.
PubMed
2) Imamura Y, et al : Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula. Am J Ophthalmol 2011 ; 151 : 297-302.
PubMed
3) Liang IC, et al : Comparison of clinical features in highly myopic eyes with and without a dome-shaped macula. Ophthalmology 2015 ; 122 : 1591-1600.
PubMed
4) Marchese A, et al : Spectrum of choroidal neovascularization associated with dome-shaped macula. Br J Ophthalmol 2019 ; 103 : 1146-1151.
PubMed
5) 今村裕 : Dome-shaped macula : その今日的意義 (総説). 眼科 2017 ; 59 : 809-814.
 
P.294 掲載の参考文献
1) Dorrell D : The tilted disc. Br J Ophthalmol 1978 ; 62 : 16-20. doi : 10.1136/bjo.62.1.16
 
2) Apple DJ, et al : Congenital anomalies of the optic disc. Surv Ophthalmol 1982 ; 27 : 3-41. doi : 10.1016/0039-6257 (82) 90111-4
 
3) 宇田千晶ら : 傾斜乳頭症候群に伴う黄斑部障害. 臨床眼科 1992 ; 46 : 1109-1113. doi : 10.11477/mf.1410901256
 
4) Nakanishi H, et al : Macular complications on the border of an inferior staphyloma associated with tilted disc syndrome. Retina 2008 ; 28 : 1493-1501. doi : 10.1097/IAE.0b013e318183589c
 
5) Kubota F, et al : Tilted Disc Syndrome Associated with Serous Retinal Detachment : Long-term Prognosis. A Retrospective Multicenter Survey. Am J Ophthalmol 2019 ; 207 : 313-318. doi : 10.1016/j.ajo.2019.05.027
 
P.298 掲載の参考文献
1) 近藤峰生ら : 黄斑ジストロフィの診断ガイドライン. 日本眼科学会雑誌 2019 ; 123 : 424-442.
 
2) Petrukhin K, et al : Identification of the gene responsible for Best macular dystrophy. Nat Genet 2008 ; 19 : 241-247.
 
3) Burgess R, et al : Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 2008 ; 82 : 19-31.
 
4) Nakanishi A, et al : Clinical and genetic findings of autosomal recessive bestrophinopathy in Japanese cohort. Am J Ophthalmol 2016 ; 168 : 86-94.
PubMed
P.301 掲載の参考文献
1) Tsang SH, et al : Stargardt disease. Adv Exp Med Biol 2018 ; 1085 : 139-151.
PubMed
2) Allikmets R, et al : A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997 ; 15 : 236-246.
PubMed
3) Tanaka K, et al : The rapid-onset chorioretinopathy phenotype of ABCA4 disease. Ophthalmology 2018 ; 125 : 89-99.
PubMed
P.305 掲載の参考文献
1) Miyake Y, et al : Hereditary macular dystrophy without visible fundus abnormality. Am J Ophthalmol 1989 ; 108 : 292-299.
PubMed
2) Miyake Y, et al : Occult macular dystrophy. Jpn J Ophthalmol 2015 ; 59 : 71-80.
PubMed
3) Akahori M, et al : Dominant Mutations in RP1L1 Are Responsible for Occult Macular Dystrophy. Am J Hum Genet 2010 ; 87 : 424-429.
PubMed
4) Tsunoda K, et al : Clinical characteristics of occult macular dystrophy in family with mutation of Rp1L1 Gene. Retina 2012 ; 32 : 1135-1147.
PubMed
5) Fujinami K, et al : Novel RP1L1 variants and genotype-photoreceptor microstructural phenotype associations in cohort of Japanese patients with occult macular dystrophy. Invest Ophthalmol Vis Sci 2016 ; 57 : 4837-4846.
PubMed
6) Nakamura N, et al : Clinical stages of occult macular dystrophy based on optical coherence tomographic findings. Invest Ophthalmol Vis Sci 2019 ; 60 : 4691-4700.
PubMed
P.308 掲載の参考文献
『難病情報センター』黄斑ジストロフィー https://www.nanbyou.or.jp/entry/4799
 
P.311 掲載の参考文献
1) Ober MD : Stellate nonhereditary idiopathic foveomacular retinoschisis. Ophthalmology 2014 ; 121 : 1406-1413.
PubMed
2) Maruko I : Clinical characteristics of idiopathic foveomacular retinoschisis. Retina 2016 ; 36 : 1486-1492.
PubMed
P.314 掲載の参考文献
1) Carins JD, et al : Microholes of the fovea centralis. Aust NZ J Ophthalmol 1988 ; 16 : 75-79.
 
2) Zambarakji HJ, et al : Macular microholes : pathogenesis and natural history. Br J Ophthalmol 2005 ; 89 : 189-193.
PubMed
3) Li YH, et al : Spectral-domain optical coherence tomography finding of acute retinal pigment epitheliitis. Taiwan J Ophthalmol 2019 ; 9 : 276-279.
PubMed
i) 飯田 知弘ら (編) : 眼底疾患パーフェクトアトラス. 東京 : 文光堂 ; 2017.
 
ii) 岸 章治 (編) : OCT眼底診断学 第3版. 東京 : エルゼビア・ジャパン : 2014.
 
P.318 掲載の参考文献
1) Sarraf D, et al : Paracentral acute middle maculopathy : a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol 2013 ; 131 : 1275-1287.
PubMed
2) Rahimy E, et al : Paracentral acute middle maculopathy in nonischemic central retinal vein occlusion. Am J Ophthalmol 2014 ; 158 : 372-380.
PubMed
3) Yu S, et al : The spectrum of superficial and deep capillary ischemia in retinal artery occlusion. Am J Ophthalmol 2015 ; 159 : 53-63.
PubMed
P.322 掲載の参考文献
1) Yannuzzi LA, et al : Unilateral acute idiopathic maculopathy. Arch Ophthalmol 1991 ; 109 : 1411-1416.
PubMed
2) Haruta H, et al : Clinical findings in unilateral acute idiopathic maculopathy : new findings in acute idiopathic maculopathy. Int Ophthalmol 2010 ; 30 : 199-202.
PubMed
3) Hashimoto Y, et al : Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy. Jpn J Ophthalmol 2015 ; 59 : 252-260.
PubMed
P.325 掲載の参考文献
1) Hobbs HE, et al : Retinopathy following chloroquine therapy. Lancet 1959 ; 2 : 478-480.
PubMed
2) Ahn SJ, et al : Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients. Am J Ophthalmol 2017 ; 184 : 11-18.
PubMed
3) Browning DJ, et al : Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol 2020 ; 219 : 101-106.
PubMed
4) Jorge A, et al : Hydroxychloroquine retinopathy-implications of research advances for rheumatology care. Nat Rev Rheumatol 2018 ; 14 : 693-703.
PubMed
5) Marmor MF, et al : Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011 ; 118 : 415-422.
PubMed
6) Marmor MF, et al : Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology 2016 ; 123 : 1386-1394.
PubMed
7) 近藤峰生ら : ヒドロキシクロロキン適正使用のための手引き. 日本眼科学会雑誌 2016 ; 120 : 419-428.
 
8) Tsang AC, et al : The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity. Am J Ophthalmol 2019 ; 206 : 132-139.
PubMed
9) Ahn SJ, et al : TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID : Evidence From Multimodal Imaging. Retina 2019 ; 39 : 1016-1026.
PubMed
10) Ahn SJ, et al : Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence : Peripheral Findings in the Retinopathy. Am J Ophthalmol 2020 ; 209 : 35-44.
PubMed
11) Kim KE, et al : Use of Optical Coherence Tomography Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening. Ophthalmology 2020. pii : S0161-6420 (20) 30562-5.
 
12) Lee DH, et al : Pericentral hydroxychloroquine retinopathy in Korean patients. Ophthalmology 2015 ; 122 : 1252-1256.
PubMed
13) Melles RB, et al : Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology 2015 ; 122 : 110-116.
PubMed
P.329 掲載の参考文献
1) Joshi MM, et al : Paclitaxel maculopathy. Arch Ophthalmol 2007 ; 125 : 709-710.
PubMed
2) Teitelbaum B, et al : Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci 2003 ; 80 : 277-279.
PubMed
3) Smith SV, et al : Cystoid macular edema secondary to albumin-bound paclitaxel therapy. Arch Ophthalmol 2008 ; 126 : 1605-1606.
PubMed
4) Kuznetcova TI, et al : The mystery of angiographically silent macular oedema due to taxanes. Int Ophthalmol 2012 ; 32 : 299-304.
PubMed
5) Nakao S, et al : Possibility of Muller Cell Dysfunction as the Pathogenesis of Paclitaxel Maculopathy. Ophthalmic Surgery, Lasers & Imaging Retina 2016 ; 47 : 81-84.
PubMed
6) Nomi N, et al : Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy. Jpn J Ophthalmol 2018 ; 62 : 163-167.
PubMed
7) Shih C-H, et al : Impaired retinal pigment epithelium in paclitaxel-induced macular edema. Medicine 2018 ; 97. doi : 10.1097/MD.0000000000011229
 
P.332 掲載の参考文献
1) McKeown CA, et al : Tamoxifen retinopathy. Br J Ophthalmol 1981 ; 65 : 177.
PubMed
2) Bourla DH, et al : Peripheral Retinopathy and Maculopathy in High-dose Tamoxifen Therapy. Am J Ophthalmol 2007 ; 144 : 126-128.
PubMed
3) Kim H-AA, et al : Prevalence and Risk Factors of Tamoxifen Retinopathy. Ophthalmology 2020 ; 127 : 555-557.
 
4) Lee S, et al : OCT Angiography Findings of Tamoxifen Retinopathy : Similarity with Macular Telangiectasia Type 2. Ophthalmol Retina 2019 ; 3 : 681-689.
PubMed
5) Shinkai A, et al : Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2 : a pathogenic hypothesis. BMC Ophthalmol 2019 ; 19 : 267.
 

書評

最近チェックした商品履歴

Loading...